Volume 3 Supplement 1

Proceedings of the 2015 Australia and New Zealand Academy for Eating Disorders (ANZAED) Conference: Riding the Waves to Recovery

Open Access

The effectiveness of enhanced cognitive behavioural therapy in an outpatient setting

  • Rachel Signorini1Email author,
  • Jeanie Sheffield1,
  • Natalie Rhodes2,
  • Carmel Fleming2 and
  • Warren Ward2
Journal of Eating Disorders20153(Suppl 1):O3


Published: 23 November 2015

The Eating Disorders Outreach Service (EDOS) at the Royal Brisbane and Women's Hospital has offered Enhanced Cognitive Behaviour Therapy (CBT-E) since 2009. The current research aimed to evaluate the effectiveness of the EDOS CBT-E program by analysing the outcome data of 114 adult outpatients (Mage = 26.06 years, SD = 8.35) with a DSM-IV diagnosis of Anorexia Nervosa, Bulimia Nervosa, or Eating Disorder Not Otherwise Specified. Outpatients attended an average of 20-40 individual sessions with a psychologist or psychiatric registrar. Of those who commenced CBT-E, only 50% completed treatment. Although a higher proportion of non-completers had an Axis II diagnosis, regression analyses revealed that the only significant predictor of drop-out from treatment was the presence of Axis IV psychosocial and environmental problems. Amongst those who completed treatment, CBT-E resulted in statistically and clinically significant improvements in eating disorder and general psychopathology, which were maintained at the 20-week follow-up. When the total sample, including non-completers was considered, statistically (and some clinically) significant improvements in eating disorder and general psychopathology were observed. The findings indicate that CBT-E is an effective treatment for adults with all eating disorders within outpatient settings. However, the high attrition observed indicates that strategies need to be identified to minimise drop-out.

Authors’ Affiliations

The University of Queensland
Eating Disorders Outreach Service


© Signorini et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.